2017
DOI: 10.1097/md.0000000000005901
|View full text |Cite
|
Sign up to set email alerts
|

Acute arterial embolism of left lower extremity caused by paradoxical embolism in Ebstein's anomaly

Abstract: Introduction:Ebstein's anomaly is a benign and stable congenital heart disease for asymptomatic patients. Despite a low incidence of Ebstein's anomaly (EA), patients’ quality of life can be badly affected by EA without positive surgical intervention. Especially EA is associated with other congenital heart disease, such as the atrial septal defect, patent foramen ovale, and arterial embolism exclude other reasons, it is often considered to be the consequence of paradoxical embolism, and surgical intervention mu… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2018
2018
2018
2018

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 28 publications
(26 reference statements)
0
2
0
Order By: Relevance
“… 8 A common complication of Ebstein’s anomaly in adults includes paradoxical embolism, which is an originally venous thrombus that transverses through a right-to-left shunt and enters the systemic circulation. 5 …”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“… 8 A common complication of Ebstein’s anomaly in adults includes paradoxical embolism, which is an originally venous thrombus that transverses through a right-to-left shunt and enters the systemic circulation. 5 …”
Section: Discussionmentioning
confidence: 99%
“… 3 , 4 Ebstein’s anomaly is a rare congenital heart disease that may be associated with right-to-left shunts that predisposes to paradoxical embolization. 5 Anticoagulant therapy is the initial treatment for venous thrombosis. Patients usually receive long-term anticoagulation therapy, such as warfarin or direct oral anticoagulants, which include dabigatran and rivaroxaban, to prevent recurrent thrombosis, embolism, and other late complications.…”
mentioning
confidence: 99%